Archives

by in
Entry Author Date Location
Afraxis Licenses its Drug Compounds to Roche Subsidiary Genentech 01/29/13 San Diego
Carl Icahn Nominates Scripps Researcher to Biogen Idec Board, BrainCells Pursues New Drug Combo for Depression, Illumina Adds to Oxford Nanopore Investment, & More San Diego Life Sciences News 02/04/10 San Diego
San Diego’s aFraxis Studies Drug Candidates to Treat Fragile X Syndrome 02/03/10 San Diego
Page 1 of 1